471
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Stabilization of Aspergillus parasiticus cytosine deaminase by immobilization on calcium alginate beads improved enzyme operational stability

, , &
Pages 1217-1220 | Received 23 Jul 2012, Accepted 19 Aug 2012, Published online: 03 Oct 2012

References

  • Ireton GC, McDermott G, Black ME, Stoddard BL. The structure of Escherichia coli cytosine deaminase. J Mol Biol 2002;315:687–697.
  • Hamaji Y, Fujimori M, Sasaki T, Matsuhashi H, Matsui-Seki K, Shimatani-Shibata Y et al. Strong enhancement of recombinant cytosine deaminase activity in Bifidobacterium longum for tumor-targeting enzyme/prodrug therapy. Biosci Biotechnol Biochem 2007;71:874–883.
  • Kievit E, Bershad E, Ng E, Sethna P, Dev I, Lawrence TS et al. Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts. Cancer Res 1999;59:1417–1421.
  • Katsuragi T, Shibata M, Sakai T, Tonomura K. Stabiliation of cytosine deaminase from Baker’s yeast by immobilization. Agric Biol Chem 1989;53:1515–1523.
  • Nishiyama T, Kawamura Y, Kawamoto K, Matsumura H, Yamamoto N, Ito T et al. Antineoplastic effects in rats of 5-fluorocytosine in combination with cytosine deaminase capsules. Cancer Res 1985;45:1753–1761.
  • Zanna H, Nok AJ, Ibrahim S, Inuwa HM. Purification and characterization of Aspergillus parasiticus cytosine deaminase for possible deployment in suicide gene therapy. Adv Biol Chem 2012;2:152–159.
  • Haq IU, Ali S, Qadeer MA. Influence of dissolved oxygen concentration on intracellular pH for regulation of Aspergillus niger growth rate during citric acid fermentation in a stirred tank bioreactor. Int J Biol Sci 2005;1:34–41.
  • Zanna H, Nok AJ, Ibrahim S, Inuwa HM. Screening some Aspergillus fungi for cytosine deaminase activity. Int J Biotechnol Biochem 2011;7:397–403.
  • Ipata PL, Cercignani G. Cytosine and cytidine deaminase from yeast. Meth Enzymol 1978;51:394–400.
  • Mahan SD, Ireton GC, Knoeber C, Stoddard BL, Black ME. Random mutagenesis and selection of Escherichia coli cytosine deaminase for cancer gene therapy. Protein Eng Des Sel 2004;17:625–633.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.